Kaletra (Lopinavir 200 mg / Ritonavir 50 mg) — Patient Information (Australia)

Kaletra is an antiretroviral medicine used to treat human immunodeficiency virus (HIV) infection in adults and children. It contains two active medicines:

• Lopinavir 200 mg
• Ritonavir 50 mg

This page explains how Kaletra works, how it is usually used, key safety information, and practical tips for taking it. It is written to be clear and patient-friendly for people in Australia.

Basic product information

Important: HIV medicines work best when taken consistently and as part of a complete regimen. Your treatment plan may be tailored based on your prior HIV treatment history, resistance testing, other health conditions, and medication interactions.

How Kaletra works (mechanism of action)

Kaletra belongs to the class of protease inhibitors. HIV protease is an enzyme the virus needs to cut long viral proteins into smaller functional proteins. Without this step, new HIV particles cannot mature properly and become less able to infect new cells.

• Lopinavir inhibits HIV protease.
• Ritonavir “boosts” lopinavir by slowing its breakdown in the body, increasing lopinavir levels in the bloodstream.

This combination helps maintain effective drug concentrations to suppress HIV viral load and support immune system recovery.

Pharmacokinetics (how the body processes Kaletra)

Key pharmacokinetic points help explain why dosing and interactions matter:

• Absorption: Lopinavir is absorbed after oral administration. Food can significantly affect exposure (see food interactions below).
• Metabolism: Lopinavir is metabolised primarily by liver enzymes (notably CYP3A). Ritonavir strongly inhibits CYP3A, increasing lopinavir exposure.
• Half-life: The presence of ritonavir prolongs lopinavir exposure so it can be dosed as recommended in the regimen.
• Distribution: Lopinavir distributes into tissues; however, effectiveness depends on maintaining levels over time.
• Excretion: Metabolites are eliminated mainly via liver/bile pathways.

Why this matters: Because Kaletra relies on liver enzymes for processing, medicines that affect CYP3A can change Kaletra levels—sometimes making it less effective or increasing side effects.

What Kaletra is used for (indications)

Kaletra is used for the treatment of HIV infection in combination with other antiretroviral medicines.

It may be used in adults and children, depending on dosing requirements, viral resistance patterns, and clinical guidance. Your HIV specialist will select the regimen that best balances effectiveness, safety, and drug-interaction risk.

Typical use and timing

Kaletra is usually taken twice daily or as directed in your regimen (some paediatric and special circumstances may use different schedules). Consistency is important because interruptions can allow viral replication and may contribute to resistance.

General timing tips

• Take at the same times each day to maintain steady drug levels.
• With food when required: certain dosing instructions advise taking with meals due to food effects on exposure.
• Do not double up if you miss a dose unless your clinician or pharmacist instructs you to do so.
• Use a daily routine (e.g., breakfast and dinner) and consider medication alarms.

If you miss a dose

Guidance can vary depending on how close the missed dose is to the next scheduled dose. In general:

• If you remember soon after the missed time, take it when you can.
• If it is close to the next dose, skip the missed dose and take the next one at the usual time.
• Check with your pharmacist for personalised advice based on your dosing schedule and formulation.

Food interactions

Food can affect the absorption and effectiveness of Kaletra. For many regimens, dosing instructions include taking Kaletra with food or at least according to the product directions you were given.

Practical food-related guidance

• Follow “with food” instructions from your prescriber/pharmacist and the product label.
• Try to eat consistently around your dose times (for example, with breakfast and dinner).
• If you experience nausea, diarrhoea, or stomach upset, taking with food (as directed) may help.

Grapefruit and related products: Because grapefruit can affect CYP3A and drug levels, it is commonly advised to avoid grapefruit when taking many protease inhibitors, including boosted regimens. Discuss any dietary supplements or “natural” products with your pharmacist.

Alcohol interactions

Moderate alcohol use may be possible for some people, but there are important considerations:

• Liver safety: Both HIV infection and antiretroviral medicines can affect liver function in some people. Alcohol may increase strain on the liver.
• Side effects: Alcohol can worsen common side effects such as nausea, dizziness, fatigue, and diarrhoea.

Recommendation: If you have hepatitis B or C, fatty liver disease, or a history of liver inflammation, discuss alcohol use with your healthcare team. Avoid heavy drinking, and consider abstaining if liver enzymes are elevated.

Medicine interactions (very important)

Kaletra has significant drug–drug interaction potential because ritonavir strongly affects liver enzymes (especially CYP3A) and transport proteins. This can either:

• Reduce Kaletra levels (leading to loss of HIV control), or
• Increase Kaletra or other drug levels (leading to toxicity or serious adverse effects).

Examples of medicines that may be affected

The list below is not complete. Always tell your pharmacist about all medicines, including over-the-counter products and supplements.

• Anticonvulsants (e.g., some medicines for epilepsy) may change Kaletra levels.
• Anticoagulants (blood thinners) may have changed effect.
• Antimycobacterials (e.g., for tuberculosis) may interact.
• Hormonal contraceptives may not be as reliable in some boosted regimens—discuss contraception options.
• Statins (cholesterol medicines) may require dose adjustment or switching due to muscle-risk concerns.
• Antifungals and macrolide antibiotics can strongly alter drug levels.
• Herbal products such as St John’s wort can significantly reduce effectiveness and are generally avoided.

Anti-reflux and similar medicines

Some medicines for reflux (acid suppression) can alter absorption. Often, they can still be used, but the interaction depends on the specific medicine and dose. Ask your pharmacist about your exact regimen.

What to do

• Keep an up-to-date medication list.
• Check interactions whenever a new medicine is started, including antibiotics, antifungals, pain medicines, and herbal supplements.
• Seek urgent advice if you experience severe symptoms (e.g., fainting, severe dizziness, rash with swelling, unusual bleeding).

Dosing overview

Dosing depends on:

• Your age and weight (especially in children)
• Your formulation (capsules vs oral solution)
• Whether you are treatment-naïve or switching from another regimen
• Potential drug interactions
• Your clinical response and any resistance testing

Common adult dosing: Many regimens use a twice-daily approach for Kaletra. Your clinician will specify the exact number of tablets/capsules per dose and schedule.

Do not adjust the dose yourself. If side effects or tolerability issues occur, talk to your pharmacist or HIV clinic. Dose changes may affect viral suppression and safety.

Practical dosing tips

• Take exactly as directed, including timing relative to meals.
• If using oral solution, measure doses carefully with an appropriate measuring device.
• Store correctly according to the label (including temperature and protection from moisture).

Safety profile and monitoring

Like all medicines, Kaletra can cause side effects. Not everyone experiences them, and many can be managed with monitoring or supportive care.

Common side effects

• Diarrhoea
• Nausea or stomach discomfort
• Headache
• Fatigue
• Rash (varies by individual)

Important potential risks

Some risks require closer monitoring:

• Liver problems: Elevated liver enzymes and hepatitis-related changes can occur, especially in people with existing liver disease (e.g., hepatitis B or C).
• Changes in lipids: Some people experience increased cholesterol or triglycerides.
• Heart rhythm effects: In susceptible individuals, protease inhibitors may be associated with conduction issues. Your clinician may consider your overall risk factors.
• Pancreatitis: Rarely, inflammation of the pancreas can occur, sometimes linked with triglyceride elevations or other factors.
• Immune reconstitution inflammatory syndrome (IRIS): When HIV improves, inflammation may reveal or unmask certain infections.
• Metabolic and body composition changes: Long-term antiretroviral therapy can affect fat distribution in some people.

When to seek urgent help

Seek medical attention promptly if you have:

• Severe or persistent vomiting, severe abdominal pain (especially upper abdominal pain)
• Yellowing of skin/eyes (jaundice), dark urine, or severe tiredness with worsening symptoms
• Fainting, severe dizziness, chest pain, or a fast/irregular heartbeat
• Allergic-type reactions such as facial swelling, difficulty breathing, or extensive blistering rash

Monitoring commonly recommended in HIV care

• Viral load and CD4 count per clinic schedule
• Liver function tests
• Fasting or non-fasting lipids (cholesterol/triglycerides)
• Blood glucose when indicated
• Other tests depending on co-morbidities and interacting medicines

Practical use tips for best results

• Adherence is critical: Taking Kaletra consistently helps achieve and maintain HIV viral suppression.
• Plan for routine: Pair dosing with meals and use reminders.
• Check interactions before starting anything new: Even common products (some sleep aids, herbal supplements, and antibiotics) can interact.
• Manage gastrointestinal effects: Stay hydrated if diarrhoea occurs and report persistent symptoms to your pharmacist or clinician.
• Keep track of side effects: Note timing, severity, and any new symptoms—this helps your healthcare team adjust supportive care.
• Store safely: Keep medication in a cool, dry place and out of reach of children.

Alternative options (discuss with your HIV care team)

There are many antiretroviral treatment options for HIV. Alternatives to a lopinavir/ritonavir regimen may include:

• Other protease inhibitors (sometimes without ritonavir boosting, depending on the medicine)
• Integrase strand transfer inhibitors (INSTIs) (commonly used in many modern regimens)
• Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
• Nucleos(t)ide reverse transcriptase inhibitors (NRTIs) as part of combination therapy

The “best” alternative depends on factors such as drug resistance, past medication history, co-infections, pregnancy plans, kidney/liver function, and interactions with other medicines (including hormone therapy and cholesterol medications). Your HIV specialist can guide what is appropriate for you.

Market and legal context in Australia

In Australia, HIV medicines are regulated under the Therapeutic Goods Act and related systems overseen by the TGA (Therapeutic Goods Administration). Use of antiretroviral therapy occurs under established clinical guidance and standard HIV care pathways.

Availability of specific formulations (capsules vs oral solution) can vary by supplier and stock levels. Many people access HIV medicines through specialist care, public/private pharmacy arrangements, and—where relevant—medication assistance programs.

Note: Online pharmacy listings typically reflect availability at the time of ordering and may require verification of eligibility and identification to comply with Australian regulatory requirements.

Recent guidance (high-level overview)

HIV treatment recommendations evolve as new medicines and evidence become available. In Australia, clinicians commonly follow guidance from bodies such as:

• Australian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM)
• National guidelines and evolving clinical protocols for antiretroviral selection and monitoring
• International standards that influence local practice

When boosted protease inhibitors like Kaletra are used, clinicians usually consider:

• Drug–drug interaction risk (including with cholesterol meds, seizure medicines, antimycobacterials, and hormonal therapies)
• Baseline and follow-up monitoring for liver enzymes, lipids, and overall safety
• Resistance testing and treatment history
• Adherence barriers (tolerability, food requirements, pill burden)

If you are switching regimens, your clinician may plan a structured transition to maintain viral suppression and minimise interaction issues.

Delivery and availability (online pharmacy)

Availability of Kaletra can vary due to formulation and supplier logistics. When ordering online in Australia, delivery options may include:

• Standard delivery within business days (timelines vary by state/territory and carrier)
• Express delivery where available
• Packaging and dispatch designed to protect medication from moisture and temperature extremes

Delivery timeframes may change during public holidays and peak periods. Some customers may receive tracking details by email or SMS.

Tip: If you need the medicine urgently, check the estimated dispatch/ delivery times shown at checkout and contact the pharmacy support team for stock confirmation.

FAQ — Frequently asked questions

1) What is Kaletra used for?

Kaletra is used to treat HIV infection as part of combination antiretroviral therapy. It suppresses HIV replication by inhibiting HIV protease.

2) How often should Kaletra be taken?

Many adult regimens use a twice-daily schedule, but your exact timing and dose depend on your formulation and your treatment plan. Follow the directions provided for your regimen.

3) Should I take Kaletra with food?

Food can affect absorption. Many dosing instructions recommend taking Kaletra with food. Follow your product label and pharmacist/clinic instructions for your specific regimen.

4) Can I drink alcohol while taking Kaletra?

Alcohol may increase side effects and may affect liver health. If you have liver disease or abnormal liver tests, discuss alcohol with your healthcare team. Avoid heavy drinking.

5) What medicines should I avoid with Kaletra?

Many medicines can interact due to CYP3A effects. This includes certain prescription medicines, some over-the-counter products, and herbal supplements (especially St John’s wort). Always ask your pharmacist before starting anything new.

6) What side effects are common?

Common side effects include diarrhoea, nausea, headache, and tiredness. Report persistent or severe symptoms to your healthcare team.

7) When should I seek urgent medical care?

Seek urgent help if you develop signs such as severe abdominal pain (possible pancreatitis), yellow skin/eyes (liver issues), fainting or severe dizziness (possible heart rhythm issues), or signs of a serious allergic reaction.

8) What monitoring is needed?

Regular monitoring typically includes viral load and CD4 count, liver function tests, and blood lipids (cholesterol/triglycerides), along with other tests based on your health and medications.

9) Is Kaletra appropriate for children?

Kaletra can be used in children, depending on age and weight and the appropriate formulation. Dosing must be calculated carefully and monitored closely.

10) What if I miss a dose?

Take it when you remember if it is not too close to the next dose; otherwise skip and continue your normal schedule. Ask your pharmacist for guidance specific to your timing.

Further information

If you have questions about how Kaletra fits into your HIV treatment plan, side effect management, or potential interactions with your other medicines, your pharmacist is a great first point of contact. For HIV-related emergencies or severe symptoms, contact emergency services or your clinical team immediately.